FindTrial
Sign In

The number of patients with dry eye and meibomian gland dysfunction in Type 2 diabetic patients at a tertiary eye care centre

Prevalence of dry eye and meibomian gland dysfunction(MGD) in Type 2 diabetic patients at a tertiary eye care centre

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/02/049820
Enrollment
214
Registered
2023-02-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H578- Other specified disorders of eye and adnexa

Interventions

None listed

Sponsors

Sankara Eye Hospital Guntur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed Type 2 diabetes patients (Duration > 5 years)

Exclusion criteria

Exclusion criteria: 1. Patients with Type 1 diabetes 2. Patients with Pterygium and thyroid disease 3. Patients who used chronic ocular drugs such as Anti histamines 4. All pregnant women 5. Patients on Anti depressants 6. Patients who underwent ocular surgery in the past 3 months 7. Patients with history of contact lens wear and Lasik surgery 8. Patients with Lid abnormalities

Design outcomes

Primary

MeasureTime frame
To evaluate dry eye and meibomian gland dysfunction among Type 2 diabetic patientsTimepoint: On the day of presentation—

Secondary

MeasureTime frame
To evaluate dry eye and meibomian gland dysfunction among Type 2 diabetic patientsTimepoint: On the day of presentation—

Countries

India

Contacts

Public ContactDr Haritha Veluri

Sankara Eye Hospital Guntur

drharitha886@yahoo.co.in6301133957

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026